Knuth Rass

Summary

Country: Germany

Publications

  1. ncbi [Systemic treatment of melanoma. Current clinical trials]
    A Hauschild
    Schwerpunktbereich Dermato Onkologie und Operative Dermatologie, Klinik fur Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig Holstein Campus Kiel, Kiel, Deutschland
    Hautarzt 59:484-91. 2008
  2. ncbi [Experimental treatment of malignant melanoma and its rationale]
    K Rass
    Klinik fur Dermatologie, Venerologie und Allergologie, Universitatsklinikum des Saarlandes, 66421, Homburg, Deutschland
    Hautarzt 59:475-83. 2008
  3. ncbi Treatment of melanoma and nonmelanoma skin cancer
    Knuth Rass
    Clinic for Dermatology, Venerology and Allergology, The Saarland University Hospital, 66421 Homburg Saar, Germany
    Adv Exp Med Biol 624:296-318. 2008
  4. ncbi UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer
    Knuth Rass
    Clinic for Dermatology, Venerology and Allergology, The Saarland University Hospital, 66421 Homburg Saar, Germany
    Adv Exp Med Biol 624:162-78. 2008
  5. ncbi Chemotherapeutics, chemoresistance and the management of melanoma
    K Rass
    Clinic for Dermatology, Venerology and Allergology, The Saarland University Hospital, Homburg, Germany
    G Ital Dermatol Venereol 144:61-78. 2009
  6. ncbi Venoarterial flow index steadily improves after endovenous laser treatment of the great saphenous vein
    Knuth Rass
    Department of Dermatology, Venereology, and Allergology, Saarland University Hospital, Homburg, Germany
    Dermatol Surg 36:1691-9. 2010
  7. ncbi Construction and evaluation of a multidimensional score to assess varicose vein severity - the Homburg Varicose Vein Severity Score (HVVSS)
    Knuth Rass
    Department of Dermatology, Venerology and Allergology, Saarland University Hospital, 66421 Homburg, Germany
    Eur J Dermatol 21:577-84. 2011
  8. ncbi Comparable effectiveness of endovenous laser ablation and high ligation with stripping of the great saphenous vein: two-year results of a randomized clinical trial (RELACS study)
    Knuth Rass
    Department of Dermatology, Venerology and Allergology, Saarland University Hospital, 66421 Homburg, Germany
    Arch Dermatol 148:49-58. 2012
  9. ncbi High-throughput miRNA profiling of human melanoma blood samples
    Petra Leidinger
    Institute of Human Genetics, Medical School, Saarland University, Building 60, 66421 Homburg Saar, Germany
    BMC Cancer 10:262. 2010
  10. ncbi [Therapy of malignant melanoma. First-, second- and pathogenesis-oriented third-line therapies]
    K Rass
    Klinik fur Dermatologie, Venerologie und Allergologie, Universitatsklinikum des Saarlandes, 66421 Homburg
    Hautarzt 57:773-84. 2006

Detail Information

Publications17

  1. ncbi [Systemic treatment of melanoma. Current clinical trials]
    A Hauschild
    Schwerpunktbereich Dermato Onkologie und Operative Dermatologie, Klinik fur Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig Holstein Campus Kiel, Kiel, Deutschland
    Hautarzt 59:484-91. 2008
    ..This overview delineates the most important clinical trials currently conducted or planned in the adjuvant and palliative setting of melanoma treatment...
  2. ncbi [Experimental treatment of malignant melanoma and its rationale]
    K Rass
    Klinik fur Dermatologie, Venerologie und Allergologie, Universitatsklinikum des Saarlandes, 66421, Homburg, Deutschland
    Hautarzt 59:475-83. 2008
    ..It will be challenging for the future to identify and characterize more precisely those patients who might most benefit from a certain treatment approach...
  3. ncbi Treatment of melanoma and nonmelanoma skin cancer
    Knuth Rass
    Clinic for Dermatology, Venerology and Allergology, The Saarland University Hospital, 66421 Homburg Saar, Germany
    Adv Exp Med Biol 624:296-318. 2008
    ....
  4. ncbi UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer
    Knuth Rass
    Clinic for Dermatology, Venerology and Allergology, The Saarland University Hospital, 66421 Homburg Saar, Germany
    Adv Exp Med Biol 624:162-78. 2008
    ....
  5. ncbi Chemotherapeutics, chemoresistance and the management of melanoma
    K Rass
    Clinic for Dermatology, Venerology and Allergology, The Saarland University Hospital, Homburg, Germany
    G Ital Dermatol Venereol 144:61-78. 2009
    ..The development of drugs targeting those mechanisms and their administration in combination with chemotherapy is currently one of the fascinating novel treatment approaches in melanoma...
  6. ncbi Venoarterial flow index steadily improves after endovenous laser treatment of the great saphenous vein
    Knuth Rass
    Department of Dermatology, Venereology, and Allergology, Saarland University Hospital, Homburg, Germany
    Dermatol Surg 36:1691-9. 2010
    ..The venous arterial flow index (VAFI) represents a quantitative duplex ultrasound parameter to characterize venous hemodynamics, which has not been investigated in EVLT so far...
  7. ncbi Construction and evaluation of a multidimensional score to assess varicose vein severity - the Homburg Varicose Vein Severity Score (HVVSS)
    Knuth Rass
    Department of Dermatology, Venerology and Allergology, Saarland University Hospital, 66421 Homburg, Germany
    Eur J Dermatol 21:577-84. 2011
    ..977 and 0.950 pre- and postoperatively (p<0.001). HVVSS is a suitable and reliable tool to assess disease severity in varicose vein patients and to quantify therapeutic effects of varicose vein treatment...
  8. ncbi Comparable effectiveness of endovenous laser ablation and high ligation with stripping of the great saphenous vein: two-year results of a randomized clinical trial (RELACS study)
    Knuth Rass
    Department of Dermatology, Venerology and Allergology, Saarland University Hospital, 66421 Homburg, Germany
    Arch Dermatol 148:49-58. 2012
    ..To compare the clinical efficacy and safety of endovenous laser treatment (EVLT) with high ligation and stripping (HLS) as standard treatment for great saphenous vein (GSV) insufficiency...
  9. ncbi High-throughput miRNA profiling of human melanoma blood samples
    Petra Leidinger
    Institute of Human Genetics, Medical School, Saarland University, Building 60, 66421 Homburg Saar, Germany
    BMC Cancer 10:262. 2010
    ..MicroRNA (miRNA) signatures are not only found in cancer tissue but also in blood of cancer patients. Specifically, miRNA detection in blood offers the prospect of a non-invasive analysis tool...
  10. ncbi [Therapy of malignant melanoma. First-, second- and pathogenesis-oriented third-line therapies]
    K Rass
    Klinik fur Dermatologie, Venerologie und Allergologie, Universitatsklinikum des Saarlandes, 66421 Homburg
    Hautarzt 57:773-84. 2006
    ..First clinical experiences are encouraging, but results from controlled trials have to be awaited...
  11. ncbi Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma
    Axel Hauschild
    Department of Dermatology, University Hospital of Schleswig Holstein, Campus Kiel, Schittenhelmstr 7, D 24105 Kiel, Germany
    J Clin Oncol 27:3496-502. 2009
    ..2% (arm A) and 82.9% (arm B). CONCLUSION The addition of a 4-week modified HDI induction phase to a 2-year low-dose adjuvant IFN-alpha-2b treatment schedule did not improve the clinical outcome...
  12. ncbi Reciprocal responses of fibroblasts and melanocytes to α-MSH depending on MC1R polymorphisms
    Hedwig Stanisz
    Department of Dermatology, Venerology and Allergology University Hospital of Saarland Homburg, Germany
    Dermatoendocrinol 3:259-65. 2011
    ..Thus, the MC1R seems to be not solely important for the skin pigmentary system, but also for the fibroblast function, and might influence different processes of the dermal compartment like wound healing, fibrosis and keloid formation...
  13. ncbi Frequency of colour vision deficiencies in melanoma patients: results of a prospective comparative screening study with the Farnsworth panel D 15 test including 300 melanoma patients and 100 healthy controls
    Claudia Pföhler
    Department of Dermatology, The Saarland University Hospital bInstitute for Medical Biometry, Epidemiology and Medical Informatics, Homburg Saar, Germany
    Melanoma Res 16:413-21. 2006
    ..For the use of blue vision deficiency in melanoma patients without predisposing diseases, a diligent test performance and interpretation is very important...
  14. ncbi [Differential diagnosis of verrucous skin changes. When wild warts grow rapidly...]
    K Rass
    Klinik fur Dermatologie, Venerologie und Allergologie, Universitatsklinikum des Saarlandes, Homburg
    MMW Fortschr Med 147:59-61. 2005
    ..This article gives and overview of the various types of verrucous skin changes (viral warts, seborrheic warts)...
  15. ncbi DNA mismatch repair enzyme hMSH2 in malignant melanoma: increased immunoreactivity as compared to acquired melanocytic nevi and strong mRNA expression in melanoma cell lines
    K Rass
    Department of Dermatology, The Saarland University Hospital, Homburg/Saar, Germany
    Histochem J 33:459-67. 2001
    ..In conclusion, our findings indicate that hMSH-2 may be of importance for genetic stability, tumorigenesis and progression of malignant melanoma...
  16. ncbi Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3
    N Booken
    Department of Dermatology, Venereology and Allergology, University Medical Centre Mannheim, Ruprecht Karl University of Heidelberg, Mannheim, Germany
    Leukemia 22:393-9. 2008
    ..Furthermore, CDO1 catalyzes taurine synthesis and taurine inhibits apoptosis and promotes chemoprotection. In summary, CDO1 and DNM3 may improve the diagnosis of SS and open novel clues to its pathogenesis...
  17. ncbi [Modern aspects of varicose vein surgery]
    K Rass
    Klinik fur Dermatologie, Venerologie und Allergologie, Universitatsklinikum des Saarlandes, Homburg
    Hautarzt 56:448-56. 2005
    ..This report delineates current developments in varicose vein surgery and provides information on principles, effectiveness and side effect profiles of endovascular therapy procedures...